5-(4-Nitro-phenyl)-[1,3,4]thiadiazol-2-ylamine, 95.0%, 5g

5-(5-Chlorothiophen-2-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 2.5g

valerenic acid, with analyt. Documents, 50 mg, glass packaging

7-Bromo-1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-one, 97%, 25g

3-Ethyl-8-fluoro-7-(hydroxymethyl)quinoxalin-2(1H)-one, 98%, 100mg

(E)-N1,N1,N4,N4-tetramethylbut-2-ene-1,4-diamine, 98%, 1g

1-((4-Chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazine dihydrochloride, 95.0%, 10g

2-Chloro-3'-fluoro-4'-methoxybenzophenone, 97.0%, 1g

O-Sulfo-L-serine, 95.0%, 250mg

Benzo[c][1,2,5]thiadiazole-4-carboxylic acid, 95.0%, 250mg

1-(5-Bromo-6-methylpyridin-2-yl)-4-(cyclopropylmethyl)piperazine, 97.0%, 10g

4-Fluorobenzaldehyde oxime, 95.0%, 250mg

2-(4,4-Dimethylcyclohexyl)acetic acid, 97%, 250mg